VTCN1
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
RB25449
unconjugated
Applikationshinweise
ELISA (1:64000) Western Blot (0.5-1.5 μg/mL) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
In Tris saline, pH 7.3 (0.5 % BSA, 0.02 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Krambeck, Thompson, Dong, Lohse, Park, Kuntz, Leibovich, Blute, Cheville, Kwon: "B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, Issue 27, pp. 10391-6, (2006) (PubMed).
Target
VTCN1
(V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))